close

Enter

Log in using OpenID

Leukemia Therapeutics Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

embed
Leukemia is a cancer of blood cells and therefore, are occasionally referred to as ‘blood cancer’. Most blood cells are formed in the bone marrow. In leukemia, undeveloped blood cells become cancer. Leukemia can be either acute or chronic. Acute leu
LEUKEMIA THERAPEUTICS
MARKET
Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2017-2025
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Leukemia Therapeutics Market Overview
Leukemia is a cancer of blood cells and therefore, are occasionally referred to as ‘blood cancer’.
Most blood cells are formed in the bone marrow. In leukemia, undeveloped blood cells become
cancer. Leukemia can be either acute or chronic. Acute leukemia is a fast growing cancer, which
usually gets worse rapidly. Chronic leukemia is a slow growing cancer, which gets worse slowly
over time period. The treatment and diagnosis of leukemia depends on the type of blood cell
affected and whether the leukemia is chronic or acute. Every day, billions of new blood cells are
produced in the bone marrow most of them red cells. However, leukemia leads to abnormally
high production of white cells. These leukemia cells cannot fight infection the way normal white
blood cells do, and in time adversely affect the way major organs function. Eventually, there this
not enough red blood cells to supply oxygen, enough platelets to clot the blood, or enough
normal white blood cells to fight infection.
Request Sample Copy of the Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/528
According to Center for Disease Control and Prevention (CDC), in the U. S. in 2013, 45,360
people were diagnosed with leukemia, leading to 23,549 fatalities (13,625 men and 9,924
women). Leukemia is frequently considered as a children’s condition, though it mainly affects
adults. The condition is more prevalent among men than women, and more in Caucasians than
African Americans.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
• Leukemia Therapeutics Market
• On the basis of disease condition, the global leukemia therapeutics market is classified
into:
• Acute lymphocytic leukemia
• Chronic lymphocytic leukemia
• Acute myeloid leukemia
• Chronic myeloid leukemia
• On the basis of treatment, the global leukemia therapeutics market is classified into:
• Immunotherapy
• Targeted Therapy
• Bone Marrow Transplant
• Stem Cell Therapy
Request a Customization:
https://www.coherentmarketinsights.com/insight/request-customization/528
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Similarly, in emerging economies of Asia Pacific such as China, and India, the leukemia
therapeutics market is expected to grow promptly due to presence of high unmet needs.
However, low diagnosis rate of leukemia and lack of proper healthcare facilities in few Asian and
African countries is deterring the leukemia therapeutics market growth in these regions.
According to the Centre for Disease Control (CDC), around 14.1 million people were diagnosed
with cancer in 2012, resulting in around 8.2 million fatalities. Around 19.3 million new cases of
cancer are projected to be diagnosed by 2025. Leukemia cases are projected to be more in the
developed world regions such as North America and Europe, owing to genetic factors caused by
enhanced radiation exposure. Environmental factors and unhealthy lifestyles are the factors which
add to the count. There are about 54,270 new cases of leukemia in the U. S. each year.
Request For [email protected] https://www.coherentmarketinsights.com/ongoing-insight/toc/528
Key players operating in the global leukemia therapeutics market are GSK, Eisai C., Pfizer,
Biogen, Celgene, Novartis AG, Genzyme Corporation, Roche, and Bristol Myers Squibb
Company (BMS). Companies are following new growth strategies such as product launch,
product pipeline, merger & acquisitions, clinical trials and collaboration & agreements, to
gain competitive advantage. For example, Novartis recently launched tyrosine kinase
receptor FLT-3 for the treatment of leukemia. Pfizer implemented product expansion
strategy to capture major market share, received Food and Drug Approval (FDA) for its
Bosulif drug.
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved
1/--pages
Report inappropriate content